Bio-Path Holdings, Inc., (Nasdaq:BPTH), today announced that it has entered into definitive agreements with several healthcare focused institutional investors for the issuance and sale in a registered direct offering of 808,080 shares of its common stock and warrants to purchase up to 606,060 shares of its common stock,
November 21, 2019
· 4 min read